GURUFOCUS.COM » STOCK LIST » Technology » Software » Clarivate PLC (NYSE:CLVT) » Definitions » 3-Year EPS without NRI Growth Rate

CLVT (Clarivate) 3-Year EPS without NRI Growth Rate : 18.40% (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Clarivate 3-Year EPS without NRI Growth Rate?

Clarivate's EPS without NRI for the three months ended in Mar. 2025 was $0.14.

During the past 12 months, Clarivate's average EPS without NRI Growth Rate was 47.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 18.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 8 years, the highest 3-Year average EPS without NRI Growth Rate of Clarivate was 18.40% per year. The lowest was 13.50% per year. And the median was 15.95% per year.


Competitive Comparison of Clarivate's 3-Year EPS without NRI Growth Rate

For the Information Technology Services subindustry, Clarivate's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clarivate's 3-Year EPS without NRI Growth Rate Distribution in the Software Industry

For the Software industry and Technology sector, Clarivate's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Clarivate's 3-Year EPS without NRI Growth Rate falls into.


;
;

Clarivate 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Clarivate  (NYSE:CLVT) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Clarivate 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Clarivate's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Clarivate Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Technology » Software » Clarivate PLC (NYSE:CLVT) » Definitions » 3-Year EPS without NRI Growth Rate
Traded in Other Exchanges
Address
70 St. Mary Axe, London, GBR, EC3A 8BE
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.
Executives
Andrew Miles Snyder director 111 WEST 57TH STREET, 9TH FLOOR, NEW YORK NY 10019
Bomba Jane L Okun director 4TH FLOOR, ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Saurabh Saha director C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT
Wendell E. Pritchett director TOLL BROTHERS, INC., 1140 VIRGINIA DRIVE, FORT WASHINGTON PA 19034
Michael J Angelakis director 40 MORRIS AVENUE, BRYN MAWR PA 19010
Bar Veinstein officer: President, A&G 70 ST. MARY AXE, LONDON X0 EC3 8BA
Melanie Margolin officer: Chief Legal Officer 1000 SAGAMORE PARKWAY SOUTH, LAFAYETTE IN 47905
Henry Levy officer: President, LS&H 70 ST. MARY AXE, LONDON X0 EC3 8BA
James Gordon Samson officer: President, IP Group FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE 1 8EZ
Jonathan Gear director, officer: Chief Executive Officer-Elect C/O IHS MARKIT LTD., 4TH FLOOR, ROPEMAKE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Michael M Easton officer: Senior VP, Finance/CAO 4TH FLOOR ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Stefano Maestri officer: Chief Technology Officer 70 ST MARY AXE, LONDON X0 EC3 8BA
Jonathan Mark Collins officer: Executive Vice President/CFO 50196 VENICE COURT, NORTHVILLE MI 48168
Mukhtar Ahmed officer: President, Science Group FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ
Heather Matzke-hamlin officer: Acting Chief Acctg Officer 4TH FLOOR, ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY